US › Healthcare

Genetic Technologies Ltd (GENE)

US · Healthcare · Diagnostics & Research

$2,013.00+0.17%
Last close · 2026-08-04

Latest quarter · ended 2024-06-30

Revenue
$4.8M
Revenue YoY
+5.9%
Net profit
$-5.6M
Profit YoY
+11.0%
EPS
$0.00
EPS estimate
$0.00
Net margin
-116.6%

Key statistics

Market cap
$3.7M
Forward P/E
0.0
P/B
3.29
Book value
$0.01
EPS (TTM)
$-0.02
52-week high
$2,044.50
52-week low
$1,674.19
50-day MA
$0.77
200-day MA
$1.10
Beta
0.48

Analyst view

with an average price target of $12.50.

Shareholding

Institutions
1.87%

Largest institutional holders

FundStake
BNP Paribas Arbitrage, SA0.40%
Rhumbline Advisers0.07%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Genetic Technologies Ltd — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.